These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11113711)

  • 21. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients.
    Cioffi G; Pozzoli M; Forni G; Franchini M; Opasich C; Cobelli F; Tavazzi L
    Eur Heart J; 1996 Sep; 17(9):1381-9. PubMed ID: 8880024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antithrombotic therapy in congestive heart failure].
    Adam O; Böhm M
    Herz; 2008 Feb; 33(1):20-4. PubMed ID: 18273574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Dunkman WB; Johnson GR; Carson PE; Bhat G; Farrell L; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI94-101. PubMed ID: 8500246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulation with warfarin for patients with left ventricular systolic dysfunction.
    Snowden S; Silus L
    Cardiol Rev; 2011; 19(1):36-40. PubMed ID: 21135601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A promising advance in anticoagulant therapy for patients with atrial fibrillation.
    Olsson SB
    Ital Heart J; 2004 May; 5(5):335-9. PubMed ID: 15185895
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review.
    Agarwal M; Apostolakis S; Lane DA; Lip GY
    Clin Ther; 2014 Sep; 36(9):1135-44. PubMed ID: 25146364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lone atrial fibrillation and anticoagulant therapy.
    More RS; Brack MJ; Gershlick AH
    Clin Cardiol; 1993 Jun; 16(6):504-6. PubMed ID: 8358885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?
    Katz SD
    J Cardiovasc Risk; 1995 Apr; 2(2):97-102. PubMed ID: 7606657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.
    Dries DL; Rosenberg YD; Waclawiw MA; Domanski MJ
    J Am Coll Cardiol; 1997 Apr; 29(5):1074-80. PubMed ID: 9120162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of anticoagulant treatment in patients with nonrheumatic atrial fibrillation].
    Vázquez Ruiz de Castroviejo E; Martín Rubio A; Pousibet Sanfeliu H; Lozano Cabezas C; Guzmán Herrera M; Tarabini Castellani A; Pagola Vilardebó C
    Rev Esp Cardiol; 2000 Feb; 53(2):200-4. PubMed ID: 10734752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lethal outcomes in patients with symptomatic heart failure developed after Q-wave myocardial infarction.
    Zaliūnas R; Babarskiene MR; Kavoliūniene A; Slapikiene B; Luksiene D; Slapikas R; Vencloviene J
    Medicina (Kaunas); 2004; 40(2):141-8. PubMed ID: 15007273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Actual Issues of Choosing Anticoagulant Therapy for Long-term Prophylaxis of Thromboembolic Complications].
    Duplyakov VD; Pavlova VT; Voronova LI
    Kardiologiia; 2017 Aug; 57(8):71-79. PubMed ID: 29041895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rationale for the use of anticoagulation in heart failure management.
    Pulerwitz T; Rabbani LE; Pinney SP
    J Thromb Thrombolysis; 2004 Apr; 17(2):87-93. PubMed ID: 15306743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction.
    Shavadia JS; Youngson E; Bainey KR; Bakal J; Welsh RC
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of mechanical valve replacement in patients with atrial fibrillation: impact of the maze procedure.
    Bum Kim J; Suk Moon J; Yun SC; Kee Kim W; Jung SH; Jung Choo S; Song H; Hyun Chung C; Won Lee J
    Circulation; 2012 May; 125(17):2071-80. PubMed ID: 22456472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.